6Zink W, Graf BM. Benefit-risk assessment of ropivacaine in the management of postoperative pain. Drug Saf, 2004,27 (14) : 1093- 1114.
7Cook CD, Rodefer JS, Picker MJ. Selective attenuation of the an- tinociceptive effects of mu opioids by the putative dopamine D3 ago- nist 7-OH-DPAT. Psychopharmacology ( Berl), 1999, 144 ( 3 ) : 239-247.
8Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician, 2007,10(2) :357-366.